BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2479130)

  • 1. Limb allografts in rats immunosuppressed with FK506. I. Reversal of rejection and indefinite survival.
    Arai K; Hotokebuchi T; Miyahara H; Arita C; Mohtai M; Sugioka Y; Kaibara N
    Transplantation; 1989 Nov; 48(5):782-6. PubMed ID: 2479130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Limb allograft in rats: studies on optimal maintenance dose of FK506 and development of graft-versus-host-disease (GVHD)].
    Weigao C
    Fukuoka Igaku Zasshi; 1996 Sep; 87(9):197-205. PubMed ID: 8913057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of rapamycin and FK 506 in prolonging rat hind limb allograft survival.
    Fealy MJ; Umansky WS; Bickel KD; Nino JJ; Morris RE; Press BH
    Ann Surg; 1994 Jan; 219(1):88-93. PubMed ID: 7507657
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Limb transplantation in rats: immunosuppression with FK-506.
    Min Z; Jones NF
    J Hand Surg Am; 1995 Jan; 20(1):77-87. PubMed ID: 7536766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combined immunosuppression of FK506 and RS-61443 in rat limb allotransplantation].
    Kang H; Hong GX; Wang FB; Chen ZB; Huang QS; Weng YX
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2003 May; 17(3):264-7. PubMed ID: 12822367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies of the induction and maintenance of long-term graft acceptance by treatment with FK506 in heterotopic cardiac allotransplantation in rats.
    Ochiai T; Nakajima K; Nagata M; Hori S; Asano T; Isono K
    Transplantation; 1987 Dec; 44(6):734-8. PubMed ID: 2447689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged limb allograft survival with short-term treatment with FK-506 in rats.
    Arai K; Hotokebuchi T; Miyahara H; Arita C; Mohtai M; Sugioka Y; Kaibara N
    Transplant Proc; 1989 Feb; 21(1 Pt 3):3191-3. PubMed ID: 2468256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A protocol with FK 506 for inducing unresponsiveness to murine islet allografts.
    Fukuzaki T; Gotoh M; Monden M; Dono K; Kanai T; Mori T
    Surgery; 1995 Feb; 117(2):220-5. PubMed ID: 7531371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FK506 as the sole immunosuppressive agent for prolongation of islet allograft survival in the rat.
    Yasunami Y; Ryu S; Kamei T
    Transplantation; 1990 Apr; 49(4):682-6. PubMed ID: 1691535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of single-dose administration of FK-506 on allogeneic limb transplantation in rats: is there an optimal timing of its administration?
    Gohda T; Iwasaki N; Yoshioka C; Minami A
    Plast Reconstr Surg; 2003 Apr; 111(5):1653-8. PubMed ID: 12655211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rejection of the component tissues of limb allografts in rats immunosuppressed with FK-506 and cyclosporine.
    Büttemeyer R; Jones NF; Min Z; Rao U
    Plast Reconstr Surg; 1996 Jan; 97(1):139-48; discussion 149-51. PubMed ID: 8532772
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclosporine and experimental skin allografts. II. Indefinite survival and development of specific immunologic unresponsiveness.
    Towpik E; Kupiec-Weglinski JW; Schneider TM; Tyler D; Padberg W; Araneda D; Tilney NL
    Transplantation; 1985 Dec; 40(6):714-8. PubMed ID: 3907046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of FK506 ointment (Protopic) on rat skin allograft model.
    Kim YE; Eun SC
    Transplant Proc; 2014 May; 46(4):1222-5. PubMed ID: 24815165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of long-term immunosuppression for limb transplantation using cyclosporine, tacrolimus, and mycophenolate mofetil: implications for clinical composite tissue transplantation.
    Jones NF; Hebebrand D; Buttemeyer R; Zhao M; Benhaim P; Rao U
    Plast Reconstr Surg; 2001 Mar; 107(3):777-84. PubMed ID: 11304605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WOFIE augments the immunosuppressive potency of FK-506. Window of opportunity for immunological engagement.
    Dresske B; Zavazava N; Huang DS; Lin X; Kremer B; Fändrich F
    Transpl Immunol; 1998 Dec; 6(4):243-9. PubMed ID: 10342738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of inhaled FK 506 on the suppression of acute rejection after lung transplantation: use of a rat orthotopic lung transplantation model.
    Ingu A; Komatsu K; Ichimiya S; Sato N; Hirayama Y; Morikawa M; Abe T
    J Heart Lung Transplant; 2005 May; 24(5):538-43. PubMed ID: 15896750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of corneal graft rejection by subconjunctival injection of FK-506 in a rat model of penetrating keratoplasty.
    Minamoto A; Sakata H; Okada K; Fujihara M
    Jpn J Ophthalmol; 1995; 39(1):12-9. PubMed ID: 7543958
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolongation of the rat composite tissue allograft survival by the combination of tolerogenic immature dendritic cells and short-term treatment with FK506.
    Eun SC; Baek RM; Park CG
    Transplant Proc; 2013 Jun; 45(5):1792-6. PubMed ID: 23769045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 12-day course of FK506 allows long-term acceptance of semi-identical liver allograft in inbred miniature swine.
    Oike F; Talpe S; Otsuka M; Dehoux JP; Lerut J; Otte JB; Gianello P
    Transplantation; 2000 Jun; 69(11):2304-14. PubMed ID: 10868630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerance induction to cardiac allografts by simultaneous or sequential intrathymic inoculation of disparate alloantigens.
    Shimomura K; Hardy MA; Oluwole SF
    Transplantation; 1995 Oct; 60(8):806-11. PubMed ID: 7482739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.